PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-35.05%
Negative revenue growth while PONY stands at 53.48%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-57.37%
Negative gross profit growth while PONY is at 49.53%. Joel Greenblatt would examine cost competitiveness or demand decline.
No Data
No Data available this quarter, please select a different quarter.
-12840.57%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-10932.16%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-11650.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-11650.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.05%
Share reduction while PONY is at 4.32%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-145.25%
Negative OCF growth while PONY is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-147.96%
Negative FCF growth while PONY is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-88.24%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-90.44%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-86.96%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-124.41%
Negative 10Y OCF/share CAGR while PONY stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
81.82%
OCF/share CAGR of 81.82% while PONY is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
-118.11%
Negative 3Y OCF/share CAGR while PONY stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-162.72%
Negative 10Y net income/share CAGR while PONY is at 63.21%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-217.56%
Negative 5Y net income/share CAGR while PONY is 63.21%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-335.11%
Negative 3Y CAGR while PONY is 63.21%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
20.43%
Below 50% of PONY's 132.50%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-6.22%
Negative 5Y equity/share growth while PONY is at 132.50%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-2.73%
Negative 3Y equity/share growth while PONY is at 132.50%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Cut dividends over 10 years while PONY stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while PONY stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
-43.19%
Firm’s AR is declining while PONY shows 14.29%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-48.62%
Inventory is declining while PONY stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-15.40%
Negative asset growth while PONY invests at 1.92%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-3.86%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-23.89%
We’re deleveraging while PONY stands at 38.45%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Our R&D shrinks while PONY invests at 3.25%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-12.52%
We cut SG&A while PONY invests at 44.40%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.